RhumbLine Advisers’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.09M | Buy |
|
|||||
|
2024
Q3 | $299K | Buy |
|
|||||
|
2024
Q2 | $283K | Buy |
|
|||||
|
2024
Q1 | $297K | Buy |
|
|||||
|
2023
Q4 | $300K | Buy |
|
|||||
|
2023
Q3 | $208K | Sell |
|
|||||
|
2023
Q2 | $162K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $153K | Buy |
|
|||||
|
2021
Q4 | $211K | Sell |
|
|||||
|
2021
Q3 | $229K | Buy |
|
|||||
|
2021
Q2 | $305K | Buy |
|
|||||
|
2021
Q1 | $212K | Buy |
|
|||||
|
2020
Q4 | $113K | Buy |
|